Department of Cardiology
Jingang Zheng has not added Biography.
If you are Jingang Zheng and would like to personalize this page please email our Author Liaison for assistance.
Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease.
Chinese medical journal Aug, 2017 | Pubmed ID: 28776542
Postnatal deficiency of ADAMTS1 ameliorates thoracic aortic aneurysm and dissection in mice.
Experimental physiology 12, 2018 | Pubmed ID: 30191627
Involvement of B cells in the pathophysiology of β-aminopropionitrile-induced thoracic aortic dissection in mice.
Experimental animals Aug, 2019 | Pubmed ID: 30930402
Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats.
International journal of medical sciences , 2019 | Pubmed ID: 31217731
Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel.
Clinical cardiology Jun, 2021 | Pubmed ID: 33978269
Verification of the Role of ADAMTS13 in the Cardiovascular Disease Using Two-Sample Mendelian Randomization.
Frontiers in genetics , 2021 | Pubmed ID: 34276770
Whole-Mount Kidney Clearing and Visualization Reveal Renal Sympathetic Hyperinnervation in Heart Failure Mice.
Frontiers in physiology , 2021 | Pubmed ID: 34305650
Interleukin-7 aggravates myocardial ischaemia/reperfusion injury by regulating macrophage infiltration and polarization.
Journal of cellular and molecular medicine Nov, 2021 | Pubmed ID: 34581005
Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.
Frontiers in cardiovascular medicine , 2021 | Pubmed ID: 35155621
Ischemia preconditioning alleviates ischemia/reperfusion injury-induced coronary no-reflow and contraction of microvascular pericytes in rats.
Microvascular research Jul, 2022 | Pubmed ID: 35240123
Predictive Value of the CHADS-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease.
Frontiers in cardiovascular medicine , 2022 | Pubmed ID: 35369355
The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease.
Atherosclerosis May, 2022 | Pubmed ID: 35450749
Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS).
BMC cardiovascular disorders May, 2022 | Pubmed ID: 35597912
Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
International journal of cardiology Dec, 2022 | Pubmed ID: 35970443
Evaluating the predictive value of diabetes mellitus diagnosed according to the Chinese guidelines (2020 edition) for cardiovascular events.
Diabetology & metabolic syndrome Sep, 2022 | Pubmed ID: 36163072
The triglyceride glucose index is associated with future cardiovascular disease nonlinearly in middle-aged and elderly Chinese adults.
BMC endocrine disorders Oct, 2022 | Pubmed ID: 36192720
Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia.
Circulation Feb, 2023 | Pubmed ID: 36562301
Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice.
Frontiers in cardiovascular medicine , 2022 | Pubmed ID: 36588571
The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models.
European journal of medical research Jan, 2023 | Pubmed ID: 36653875
Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit.
Cardiovascular diabetology May, 2023 | Pubmed ID: 37179310
Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials.
Frontiers in cardiovascular medicine , 2023 | Pubmed ID: 37273883
Ziyu Guo1,
Ao Wang2,
Yanxiang Gao3,
Enmin Xie4,
Zixiang Ye1,
Yike Li4,
Xuecheng Zhao3,
Nan Shen1,
Jingang Zheng1
1Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine,
2Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education,
3Department of Cardiology, China-Japan Friendship Hospital. No 2 Yinghua Dongjie,
4, Graduate School of Chinese Academy of Medical Sciences and Peking Union Medical College
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved